US Stock Price Fluctuated | HSBC bank downgrades Moderna (MRNA.US) and its stock drops more than 4%

On Monday, the stock price of Moderna (MRNA.US) fell, as of the time of writing, the stock dropped by over 4%, to $92.44. Prior to this, HSBC downgraded Moderna from "hold" to "reduce" and expressed a cautious attitude towards the overall market potential of Moderna's mRNA vaccine. They estimated the company's highest sales to be 1.7 billion US dollars, at the lower end of the consensus range of 15 to 24 billion US dollars.